Back to
UBS Group AG
SRPT30 quarters
Position history for
UBS Group AG's holdings in SAREPTA THERAPEUTICS INC
UBS Group AG holds 1.6M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $29.2M as of 2026-Q2. The position was decreased (-27.2% shares). SRPT represents 0.0% of UBS Group AG's portfolio.
Current Value
$29.2M
Current Shares
1.6M
Total Value Change
+$19.6M
Total Shares Change
+1.5M
Quarter-by-Quarter History
Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors